Related Experiment Video
Updated: Sep 19, 2025

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation
Published on: April 14, 2016
Targeting post-translational modifications: novel insights into bone metabolic diseases
Hui Kong1, Juan-Juan Han2, Guo Liang3
1College of Exercise and Health, Shenyang Sport University, Shenyang 110102, China; School of Exercise and Health and Collaborative Innovation Center for Sports and Public Health, Shanghai University of Sport, Shanghai 200438, China.
Post-translational modifications (PTMs) critically regulate bone metabolism. This review details PTMs, their interactions, and roles in bone diseases like osteoporosis, aiding new therapeutic target discovery.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Bone metabolic diseases involve abnormal bone mass and metabolism, influenced by oxidative stress and nutritional factors.
- Post-translational modifications (PTMs) are crucial for protein regulation and implicated in bone disease pathogenesis.
- Existing reviews often neglect the complex interplay and cross-talk between various PTMs in bone health.
Purpose of the Study:
- To systematically review diverse PTMs, including phosphorylation, methylation, ubiquitination, glycosylation, and novel modifications like lactylation and sulfhydration.
- To elucidate the mechanisms and interrelationships (cross-talk) among PTMs in regulating bone metabolism.
- To highlight the role of aberrant PTMs in disrupting bone homeostasis and their involvement in diseases such as osteoarthritis, osteoporosis, osteosarcoma, and rheumatoid arthritis.
Main Methods:
- Comprehensive literature review of PTMs in bone metabolic diseases.
- Analysis of regulatory mechanisms and signaling pathways affected by PTMs.
- Synthesis of current knowledge on PTM cross-talk and its impact on bone pathophysiology.
Main Results:
- Detailed overview of 15 distinct PTMs and their specific roles in bone health and disease.
- Identification of key signaling pathways regulated by PTMs, including those involved in cellular dysfunction.
- Evidence for the significant impact of PTM interplays on bone metabolic homeostasis.
Conclusions:
- Aberrant PTMs disrupt bone metabolic homeostasis, contributing to diseases like osteoarthritis and osteoporosis.
- Understanding PTM mechanisms and their cross-talk offers potential for novel therapeutic targets.
- Further research into PTMs provides a foundation for developing more effective treatments for bone metabolic disorders.
Related Concept Videos
Bone Remodeling
Osteoclasts in Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
What is the Skeletal System?
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...

